Skip to main
ABL
ABL logo

ABL Stock Forecast & Price Target

ABL Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Abacus Global Management's preliminary 3Q24 earnings indicate significant growth, with total revenue projected between $26.0M and $28.0M, reflecting a year-over-year increase of 23% to 33%, and adjusted EBITDA expected to rise by 30% to 48% year-over-year. The company's strategic acquisition activities, including the integration of Carlisle’s $2B in assets under management, are designed to diversify revenue streams and enhance its appeal to institutional investors by offering attractive risk-adjusted returns. Additionally, the positive performance metrics, such as being net income positive for the 20th consecutive year, along with a compelling outlook for the ABL Tech platform, contribute to a robust financial trajectory moving forward.

Bears say

Abacus Global Management faces significant challenges that contribute to a negative outlook, particularly due to its inability to accurately evaluate critical metrics such as market conditions, life expectancy, and associated premiums, which could diminish profitability. Additionally, the company may struggle to establish and maintain productive relationships with life insurance companies, potentially elongating transaction processes and affecting its operational efficiency. Furthermore, limited market liquidity may hinder Abacus's ability to realize the full value of acquired policies, compounding profitability concerns and disrupting their financial stability.

ABL has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Abacus Life Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Abacus Life Inc (ABL) Forecast

Analysts have given ABL a Buy based on their latest research and market trends.

According to 1 analysts, ABL has a Buy consensus rating as of Jul 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Abacus Life Inc (ABL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.